Literature DB >> 20730478

Recombinant hexahistidine arginine decarboxylase (hisADC) induced endogenous agmatine synthesis during stress.

Sung-Ung Moon1, Ki-Hyo Kwon, Jae-Hwan Kim, Kiran Kumar Bokara, Kyung Ah Park, Won Taek Lee, Jong-Eun Lee.   

Abstract

The arginine decarboxylase (ADC) is a significant functional enzyme, synthesizes agmatine through arginine metabolism, and agmatine was reported to posses protective properties in various tissues. This study first optimized the conditions for efficient hexahistidine tagged human ADC (hisADC) gene delivery into mouse fibroblast cell line (NIH3T3) using retroviral vector (pLXSN). Later, the functionality of the delivered hisADC gene in synthesizing agmatine during H(2)O(2) injury in NIH3T3 was also elucidated. Amplification of hisADC gene was performed using hisADC specific primers under specified conditions. The hisADC PCR product (1.4 kb) was ligated with pLXSN considering the restriction enzyme sites. The complete hisADC pLXSN clone was transfected into PT67 cell line following CalPhos Mammalian transfection method. RT-PCR and western blot results showed the specific and strong detection of hisADC genes in hisADC PT67 transfected cells compared with normal control and pLXSN transfected PT67 cells. The retrovirus containing hisADC gene (vhisADC) was infected into NIH3T3 (vhisADC NIH) using polybrene reagent. Immunocytochemical results showed hisADC expression in the cytoplasm of vhisADC NIH. HPLC analysis revealed high agmatine concentration in the vhisADC NIH, and the induced agmatine synthesized from the retroviral gene delivery prevented vhisADC NIH from H(2)O(2) injury which is evident by the decrease in lactate dehydrogenase (P < 0.05) leakage into the medium and less number of propidium iodide positive cells during injury compared to control group. The obtained results provide compelling evidence that higher level of hisADC transgene expression completely triggered the endogenous agmatine synthesis during H(2)O(2) injury thus protecting NIH3T3 cells against cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730478     DOI: 10.1007/s11010-010-0559-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics.

Authors:  J B Lorens; C Sousa; M K Bennett; S M Molineaux; D G Payan
Journal:  Curr Opin Biotechnol       Date:  2001-12       Impact factor: 9.740

2.  Agmatine inhibits cell proliferation and improves renal function in anti-thy-1 glomerulonephritis.

Authors:  Shunji Ishizuka; Robyn Cunard; Siria Poucell-Hatton; Lucinda Wead; Mark Lortie; Scott C Thomson; Francis B Gabbai; Joseph Satriano; Roland C Blantz
Journal:  J Am Soc Nephrol       Date:  2000-12       Impact factor: 10.121

3.  Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.

Authors:  G Olmos; N DeGregorio-Rocasolano; M Paz Regalado; T Gasull; M Assumpció Boronat; R Trullas; A Villarroel; J Lerma; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Drug target discovery using retroviruses.

Authors:  Magnus Blø; David R Micklem; James B Lorens
Journal:  Expert Opin Drug Discov       Date:  2007-10       Impact factor: 6.098

5.  Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats.

Authors:  G M Gilad; V H Gilad
Journal:  Neurosci Lett       Date:  2000-12-22       Impact factor: 3.046

6.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

7.  Agmatine improves locomotor function and reduces tissue damage following spinal cord injury.

Authors:  C G Yu; A E Marcillo; C A Fairbanks; G L Wilcox; R P Yezierski
Journal:  Neuroreport       Date:  2000-09-28       Impact factor: 1.837

8.  Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Zheng-Wei Cai; Soundar Regunathan; Gregory Ordway
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

9.  Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats.

Authors:  Yangzheng Feng; John E Piletz; Michael H Leblanc
Journal:  Pediatr Res       Date:  2002-10       Impact factor: 3.756

10.  Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B.

Authors:  Won Taek Lee; Samin Hong; Sung Hwan Yoon; Jae Hwan Kim; Kyung Ah Park; Gong Je Seong; Jong Eun Lee
Journal:  Brain Res       Date:  2009-05-22       Impact factor: 3.252

View more
  3 in total

1.  Retroviral expression of human arginine decarboxylase reduces oxidative stress injury in mouse cortical astrocytes.

Authors:  Samin Hong; Mi Ran Son; Kyungeun Yun; Won Taek Lee; Kyung Ah Park; Jong Eun Lee
Journal:  BMC Neurosci       Date:  2014-08-26       Impact factor: 3.288

2.  Restorative Mechanism of Neural Progenitor Cells Overexpressing Arginine Decarboxylase Genes Following Ischemic Injury.

Authors:  Jae Young Kim; Jong Youl Kim; Jae Hwan Kim; Hosung Jung; Won Taek Lee; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2019-01-21       Impact factor: 3.261

3.  Overexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H₂O₂ toxicity through cell survival protein activation.

Authors:  Su Kyoung Seo; Wonsuk Yang; Yu Mi Park; Won Taek Lee; Kyung Ah Park; Jong Eun Lee
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.